Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1077263

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1077263

Global Zygomatic and Pterygoid Implants Market - 2022-2029

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Market Overview

The global zygomatic and pterygoid implants market size was worth US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

The zygomatic and pterygoid implants are used when the patient has insufficient quality or quantity of bone to anchor implants of regular dimensions.

Market Dynamics

The global zygomatic and pterygoid implants market growth is driven by the growing geriatric population contributing to the increasing incidences of dental ailments and injuries and proven advantageous procedures with implants as compared to conventional substitute.

Growing adoption of zygomatic and pterygoid implants is expected to hold the largest share in this market segment

According to an October 2020 update by the World Health Organization (WHO), by 2030, 1 of every 6 individuals will be mature 60 years or above. As the maturing populace is inclined to experience dental sicknesses like maxillary resorption and expanded bone misfortune, the interest for zygomatic and pterygoid inserts is supposed to develop with the developing geriatric populace. What's more, demonstrated profitable techniques with these inserts are a central point driving the interest for zygomatic and pterygoid inserts. For example, according to an April 2021 distributed article named, "Tubero Pterygoid Implants-A Boom for Atrophied Maxillary Ridges: Systematic Review and Meta-Analysis," it was presumed that tubero-pterygoid inserts could be effectively utilized in patients with an atrophic back maxilla.

In addition, as indicated by the February 2019 distributed article named "Pterygoid embed, Option for restoration of the atrophic back maxilla," pterygoid inserts stay away from the requirement for sinus lifts and uniting strategies and permit dock in the back decayed or resorbed maxilla, accomplishing appropriate dependability, and high paces of long-haul achievement. Consequently, these examinations showing the benefits of utilizing pterygoid inserts mirror the developing reception of such embeds among the patient population.

Growing rate of complications linked to implant-associated infections is expected hamper the market growth

Implant-related contaminations (IAIs) are a feared entanglement basically brought about by biofilm-framing staphylococci. The main issue emerging from the presence of an embed in people is the unfavorably susceptible/easily affected response and incendiary reaction that might be mounted by the host's invulnerable framework against the embed/gadget. Since an embed stays for an extensive stretch going from a couple of months to quite a long while, the event of IAIs and their capability to cause extreme dismalness is much of the time a reason for genuine concern.

COVID-19 Impact Analysis

The COVID-19 episode was an uncommon well-being concern and had fundamentally affected the zygomatic inserts and pterygoid inserts market. In the first and second quarters of 2020, the flare of the COVID-19 pandemic firmly affected the zygomatic and pterygoid inserts market as an emergency clinic and dental center activities were essentially decreased because of lockdown and social separating measures attempted by legislatures across the world. In March 2020, the American Dental Association (ADA), the country's biggest dental affiliation, suggested that dental specialists defer elective dental systems until April 6, 2020, and give crisis just dental administrations to assist with holding patients back from troubling clinic crisis divisions. This suggestion was refreshed on April 1, 2020, when the ADA encouraged workplaces to stay shut to everything except dire and crisis techniques until April 30, at the earliest, inferable from the rising number of COVID-19 cases. Hence, this significantly impacted dental administrations, along these lines diminishing the interest for zygomatic and pterygoid inserts.

Segment Analysis

The independent controls segment is expected to hold the largest share in this market segment

Severe atrophy of the maxillary bone fragment is supposed to hold a significant portion of the overall industry. Bone atrophy likewise alluded to as osteonecrosis of the jaw happens when the basic jawbone starts to break down. The elements adding to the portion's development are the rising frequencies of serious decay of the maxillary bone, the developing geriatric population, and the execution of strategic initiatives by the market players.

According to a January 2021 distributed article named "Zygomatic inserts put in the atrophic maxilla: an outline of current methodical audits and meta-investigation," zygomatic inserts seem to offer a promising option in contrast to formal bone uniting strategies with lower costs, fewer complexities, less dismalness, more limited treatment times, and similarly high endurance rates, such examinations mirror the developing interest for zygomatic inserts for serious decay of the maxilla, consequently adding to the fragment's development.

Consequently, the section is supposed to develop fundamentally over the forecast period because of the variables referenced previously.

Geographical Analysis

Europe region holds the largest market share of global zygomatic and pterygoid implants market

The Europe region is anticipated to hold a major market share in the global zygomatic and pterygoid implants market due to the increasing geriatric population leading to a rise in incidence rates of dental ailments and injuries. For instance, as per a 2022 update by Eurostat Statistics, the share of people aged 80 years or above in the European region's population is projected to have a two-and-a-half-fold increase between 2021 and 2100, from 6.0% to 14.6%. Likewise, according to the European Federation of Periodontology, in Europe, periodontal diseases are the most common conditions. Eight out of ten individuals over 35 years of age suffer from gum diseases. Moreover, periodontal diseases represent a major cause of expenditure in the adult and geriatric population.

Moreover, an increasing number of orthodontic procedures contributes to market growth. For example, as per the 2019 British Orthodontic Society survey, the number of adults seeking orthodontic treatment in the United Kingdom remains high. Therefore, this indicates the high demand for zygomatic and pterygoid implants in the region, thereby contributing to the market's growth.

Competitive Landscape

The global zygomatic and pterygoid implants market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Straumann Holding AG, Noris Medical, S.I.N. Implant System, Southern Implants, IDC Implant & Dental Company, Danaher Corporation (NobelBiocare), Titaniumfix, Implance, Bioline Dental Implants and Osseosource. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the zygomatic and pterygoid implants globally. For instance, In December 2020, Nuffield Dental Group, a premium dental clinic in Singapore, launched its 10th state-of-the-art dental technology clinic in Singapore. Zygomatic implants at Nuffield are an alternative solution for weak bone density complications in a patient's upper jaw.

Key Companies to Watch

Straumann Holding AG

Overview: Headquartered in Basel, Switzerland, the Straumann Group researches and develops, manufactures and supplies dental implants, instruments, biomaterials, CADCAM prosthetics, digital equipment, software, and clear aligners for applications in replacement, restorative, orthodontic and preventative dentistry.

Product Portfolio: It includes products like Straumann Zygomatic Implant System- ZAGA Round and ZAGA Flat.

Why Purchase the Report?

Visualize the composition of the zygomatic and pterygoid implants market segmentation by product length, application, and region highlighting the key commercial assets and players.

Identify commercial opportunities in zygomatic and pterygoid implants market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of zygomatic and pterygoid implants market - level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players.

The global zygomatic and pterygoid implants market report would provide an access to an approx. 50 market data table, 35 figures and 180 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Product Code: DMMD5019

Table of Contents

1. Global Zygomatic and Pterygoid Implants Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Zygomatic and Pterygoid Implants Market - Market Definition and Overview

3. Global Zygomatic and Pterygoid Implants Market - Executive Summary

  • 3.1. Market Snippet by Product Length
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Region

4. Global Zygomatic and Pterygoid Implants Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
    • 4.1.2. Growing adoption of zygomatic and pterygoid implants
  • 4.2. Restraints:
    • 4.2.1. Growing rate of complications linked to implant-associated infections
  • 4.3. Opportunity
  • 4.4. Impact Analysis

5. Global Zygomatic and Pterygoid Implants Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. PEST Analysis

6. Global Zygomatic and Pterygoid Implants Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Zygomatic and Pterygoid Implants Market - By Product Length

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Length
    • 7.1.2. Market Attractiveness Index, By Product Length
  • 7.2. Upto 30 mm*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. 30 - 50 mm
  • 7.4. Above 50 mm

8. Global Zygomatic and Pterygoid Implants Market - By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Severe Atrophy of Maxillary Bone*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Maxillary Sinuses
  • 8.4. Other Applications

9. Global Zygomatic and Pterygoid Implants Market - By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Length
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Length
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Length
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Length
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Length
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

10. Global Zygomatic and Pterygoid Implants Market - Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Key Developments and Strategies
  • 10.3. Company Share Analysis
  • 10.4. Product Benchmarking
  • 10.5. Key Companies to Watch
  • 10.6. Company with disruptive technology

11. Global Zygomatic and Pterygoid Implants Market- Company Profiles

  • 11.1. Straumann Holding AG*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Noris Medical
  • 11.3. S.I.N. Implant System
  • 11.4. Southern Implants
  • 11.5. IDC Implant & Dental Company
  • 11.6. Danaher Corporation (NobelBiocare)
  • 11.7. Titaniumfix
  • 11.8. Implance
  • 11.9. Bioline Dental Implants
  • 11.10. Osseosource

LIST NOT EXHAUSTIVE

12. Global Zygomatic and Pterygoid Implants Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!